Figure 5.
Immunochemical measurements of MAP2 and synuclein in frontal and temporal cortex with respect to Braak stage. The first statistically significant deviation relative to the preceding stage(s) occurred at stage 4 for both parameters and only the decline in MAP2 reached significance after stage 4.